NCT05577442 2022-10-19Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast CancerPeking University Cancer Hospital & InstitutePhase 2 Unknown52 enrolled